4//SEC Filing
Mayne Pharma Ventures Pty Ltd 4
Accession 0001144204-18-037560
CIK 0001042418other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:11 PM ET
Size
16.2 KB
Accession
0001144204-18-037560
Insider Transaction Report
Form 4
Mayne Pharma International Pty Ltd
10% Owner
Transactions
- Purchase
Series B Warrants to Purchase Common Stock
2018-07-05+1,739,131→ 1,739,131 totalExercise: $0.28From: 2018-07-05Exp: 2023-07-05→ Common Stock (1,739,131 underlying) - Purchase
Series B Convertible Preferred Stock
2018-07-05+2,318,841→ 5,797,102 totalFrom: 2018-07-05→ Common Stock (6,956,523 underlying) - Purchase
Series A Warrants to Purchase Common Stock
2018-07-05+1,739,131→ 1,739,131 totalExercise: $0.23From: 2018-07-05Exp: 2020-07-05→ Common Stock (1,739,131 underlying)
Mayne Pharma Group Ltd
10% Owner
Transactions
- Purchase
Series B Convertible Preferred Stock
2018-07-05+2,318,841→ 5,797,102 totalFrom: 2018-07-05→ Common Stock (6,956,523 underlying) - Purchase
Series A Warrants to Purchase Common Stock
2018-07-05+1,739,131→ 1,739,131 totalExercise: $0.23From: 2018-07-05Exp: 2020-07-05→ Common Stock (1,739,131 underlying) - Purchase
Series B Warrants to Purchase Common Stock
2018-07-05+1,739,131→ 1,739,131 totalExercise: $0.28From: 2018-07-05Exp: 2023-07-05→ Common Stock (1,739,131 underlying)
Mayne Pharma Ventures Pty Ltd
Director10% Owner
Transactions
- Purchase
Series B Warrants to Purchase Common Stock
2018-07-05+1,739,131→ 1,739,131 totalExercise: $0.28From: 2018-07-05Exp: 2023-07-05→ Common Stock (1,739,131 underlying) - Purchase
Series B Convertible Preferred Stock
2018-07-05+2,318,841→ 5,797,102 totalFrom: 2018-07-05→ Common Stock (6,956,523 underlying) - Purchase
Series A Warrants to Purchase Common Stock
2018-07-05+1,739,131→ 1,739,131 totalExercise: $0.23From: 2018-07-05Exp: 2020-07-05→ Common Stock (1,739,131 underlying)
Footnotes (4)
- [F1]On July 5, 2018, Mayne Pharma Ventures Pty Ltd ("Mayne Ventures") acquired (i) 2,318,841 shares of Series B Convertible Preferred Stock, (ii) Series A warrants to purchase 1,739,131 shares of Common Stock in the aggregate and (iii) Series B warrants to purchase 1,739,131 shares of Common Stock directly from the Issuer in a private placement for an aggregate purchase price of US$1,600,000 at the second closing pursuant to the terms of the securities purchase agreement, dated January 8, 2018, between Mayne Ventures and the Issuer. Each share of Series B Convertible Preferred Stock (i) may be converted by Mayne Ventures at any time into three shares of Common Stock and (ii) is entitled to the number of votes equal to the number of shares of Common Stock into which each such share of Series B Convertible Preferred Stock is convertible. The Series B Convertible Preferred Stock does not have an expiration date.
- [F2]The Series A warrants have an initial exercise price of US$0.23 and may be exercised by Mayne Ventures at any time prior to their expiration on July 5, 2020.
- [F3]The Series B warrants have an initial exercise price of US$0.275 and may be exercised by Mayne Ventures at any time prior to their expiration on July 5, 2023.
- [F4]These securities are directly owned by Mayne Ventures. This report is filed jointly by Mayne Ventures, Mayne Pharma International Pty Ltd ("Mayne International") and Mayne Pharma Group Limited ("Mayne Group"). Mayne Group holds 100% of the issued and outstanding equity securities of Mayne International, and Mayne International holds 100% of the issued and outstanding equity securities of Mayne Ventures. Consequently, Mayne Group and Mayne International may be deemed to beneficially own the securities that are the subject to this report indirectly, but disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, Mayne Ventures is deemed a director by deputization by virtue of its representation on the Board of Directors of the Issuer.
Documents
Issuer
HedgePath Pharmaceuticals, Inc.
CIK 0001042418
Entity typeother
IncorporatedAustralia
Related Parties
1- filerCIK 0001611535
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:11 PM ET
- Size
- 16.2 KB